Symrise, DE000SYM9999

Symrise AG stock (DE000SYM9999): B2B aroma makers gain US market attention

11.05.2026 - 11:20:28 | ad-hoc-news.de

Symrise AG, a leading global supplier of flavors and fragrances, is among B2B aroma manufacturers drawing increased focus from US food and consumer goods firms, amid competitive dynamics in North America.

Symrise, DE000SYM9999
Symrise, DE000SYM9999

Symrise AG shares traded at €79.80 on the Frankfurt Stock Exchange (ETR), reflecting a 22.3% decline since recent highs, according to MarketBeat as of May 2026. The company, known for supplying fragrances, flavorings, and cosmetic ingredients worldwide, operates in a sector gaining traction in the US market. B2B aroma producers like Symrise are increasingly vital for American food, beverage, and consumer goods companies, as noted in recent industry coverage.

As of: 11.05.2026

By the editorial team – specialized in equity coverage.

At a glance

  • Name: Symrise AG
  • Sector/industry: Basic Materials / Specialty Chemicals
  • Headquarters/country: Holzminden, Germany
  • Core markets: Europe, North America, Asia Pacific, Latin America
  • Key revenue drivers: Fragrances, flavorings, nutrition & health
  • Home exchange/listing venue: ETR (SY1)
  • Trading currency: EUR

Official source

For first-hand information on Symrise AG, visit the company’s official website.

Go to the official website

Symrise AG: core business model

Symrise AG develops and supplies fragrances, flavorings, cosmetic active ingredients, raw materials, and functional ingredients across multiple regions including North America. Founded in 1874 and headquartered in Holzminden, Germany, the company operates through two main segments: Taste, Nutrition & Health; and Scent & Care, according to MarketBeat company overview as of May 2026. With 12,656 employees, Symrise serves industries from food and beverages to personal care.

The business model emphasizes innovation in sensory ingredients, positioning Symrise as a key B2B partner. It generates annual sales of €4.97 billion for the trailing twelve months reported as of May 2026, with a market capitalization around €11.5 billion on ETR:SY1.

Main revenue and product drivers for Symrise AG

Symrise AG's revenue is driven by its Taste, Nutrition & Health segment, which includes flavorings for food and beverages, and functional ingredients. The Scent & Care division covers fragrances and cosmetic actives. Trailing twelve-month net income stood at €399.72 million with EPS of €2.75 as of May 2026 per MarketBeat data as of May 2026. Key drivers include demand in North America, where US firms rely on such suppliers.

Recent sector attention highlights Symrise alongside peers like IFF and Givaudan in the US market for aromas used in consumer products, according to Ad-hoc-News as of recent publication.

Industry trends and competitive position

The specialty chemicals industry, particularly flavors and fragrances, benefits from rising US demand in food processing and personal care. Symrise holds a strong position with a P/E ratio of 29.39 and dividend yield of 1.36% based on trailing data as of May 2026 from MarketBeat. Its beta of 0.49 indicates lower volatility compared to the market.

Competitors dominate globally, but Symrise's North American presence appeals to US investors tracking exposure to stable consumer staples supply chains.

Why Symrise AG matters for US investors

Symrise AG offers US investors indirect exposure to resilient sectors like food flavorings and cosmetics, with significant North American operations. Listed on ETR:SY1 in EUR, it provides diversification into European specialty chemicals amid US market growth for B2B aromas. Recent trading at €79.40 with a 0.18% gain underscores steady interest, per Investing.com as of May 2026.

Read more

Additional news and developments on the stock can be explored via the linked overview pages.

More news on this stockInvestor relations

Conclusion

Symrise AG continues to navigate a competitive landscape in flavors and fragrances, with recent US market attention for B2B providers and stable financial metrics like €4.97 billion in sales. Shares have faced pressure with a 22.3% drop from highs, trading around €79-80 on ETR. Investors monitor segment performance and North American demand amid global operations.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.

So schätzen die Börsenprofis Symrise Aktien ein!

<b>So schätzen die Börsenprofis  Symrise Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
en | DE000SYM9999 | SYMRISE | boerse | 69303631 | bgmi